STRS Ohio’s Fulcrum Therapeutics FULC Stock Holding History

STRS Ohio’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$169K	Sell	46,200 -3,100	-6%	-$18.9K	﹤0.01%	1674
2026 Q1	$378K	Hold	49,300	–	–	﹤0.01%	1227
2025 Q4	$558K	Sell	49,300 -28,600	-37%	-$291K	﹤0.01%	986
2025 Q3	$717K	Buy	77,900 +2,800	+4%	+$20.3K	﹤0.01%	824
2025 Q2	$517K	Sell	75,100 -16,100	-18%	-$86.1K	﹤0.01%	1268
2025 Q1	$263K	Hold	91,200	–	–	﹤0.01%	1437
2024 Q4	$429K	Hold	91,200	–	–	﹤0.01%	1260
2024 Q3	$326K	Buy	+91,200	New	+$677K	﹤0.01%	1421
2022 Q3	–	Sell	-6,800	Closed	-$33K	–	2030
2022 Q2	$33K	Hold	6,800	–	–	﹤0.01%	1915
2022 Q1	$160K	Sell	6,800 -1,000	-13%	-$14.2K	﹤0.01%	1765
2021 Q4	$137K	Hold	7,800	–	–	﹤0.01%	1830
2021 Q3	$220K	Buy	7,800 +4,600	+144%	+$87.2K	﹤0.01%	1744
2021 Q2	$33K	Hold	3,200	–	–	﹤0.01%	2148
2021 Q1	$37K	Hold	3,200	–	–	﹤0.01%	2064
2020 Q4	$37K	Hold	3,200	–	–	﹤0.01%	2023
2020 Q3	$25K	Hold	3,200	–	–	﹤0.01%	2063
2020 Q2	$58K	Hold	3,200	–	–	﹤0.01%	1884
2020 Q1	$38K	Buy	3,200 +2,000	+167%	+$32K	﹤0.01%	1821
2019 Q4	$19K	Hold	1,200	–	–	﹤0.01%	1977
2019 Q3	$7K	Buy	+1,200	New	+$13.3K	﹤0.01%	2042

Other funds holding FULC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

STRS Ohio's FULC Position: Q2 2026 in Review

STRS Ohio reduced its Fulcrum Therapeutics (FULC) stake by 6.3% in Q2 2026, selling an estimated $18.9K and leaving 46,200 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #1674.

STRS Ohio first reported a position in FULC in Q3 2019 and has held it in 20 quarters since. The position peaked at $717K in Q3 2025. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

STRS Ohio held 46,200 shares of Fulcrum Therapeutics worth $169K as of Q2 2026.
STRS Ohio sold 3,100 Fulcrum Therapeutics shares in Q2 2026, an estimated $18.9K.
Fulcrum Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1674 holding.
STRS Ohio first reported a position in Fulcrum Therapeutics in Q3 2019 and has held it in 20 quarters since.
STRS Ohio's Fulcrum Therapeutics position peaked at $717K in Q3 2025.
155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.